(VIANEWS) – Sarepta Therapeutics (SRPT), QuickLogic Corporation (QUIK), Argan (AGX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Sarepta Therapeutics (SRPT)
45.4% sales growth and 5.2% return on equity
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company offers EXONDYS 51 injection to treat duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of DMD in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping. It also developing AMONDYS 45, a product candidate that uses phosphorodiamidate morpholino oligomer (PMO) chemistry and exon-skipping technology to skip exon 45 of the dystrophin gene; SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; SRP-9001, a DMD micro-dystrophin gene therapy program; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. The company has collaboration agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Lysogene; Duke University; Genethon; and StrideBio. It also has a research and option agreement with Codiak BioSciences, Inc. to design and develop engineered exosome therapeutics to deliver gene therapy, gene editing, and RNA technologies for neuromuscular diseases; and research collaboration with Genevant Sciences for lipid nanoparticle-based gene editing therapeutics. Sarepta Therapeutics, Inc. was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
Earnings Per Share
As for profitability, Sarepta Therapeutics has a trailing twelve months EPS of $0.75.
PE Ratio
Sarepta Therapeutics has a trailing twelve months price to earnings ratio of 180.13. Meaning, the purchaser of the share is investing $180.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.2%.
Volume
Today’s last reported volume for Sarepta Therapeutics is 676703 which is 56.17% below its average volume of 1544250.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 65.2% and 187.2%, respectively.
Moving Average
Sarepta Therapeutics’s value is under its 50-day moving average of $145.18 and higher than its 200-day moving average of $123.45.
Previous days news about Sarepta Therapeutics(SRPT)
- Implied volatility surging for sarepta therapeutics (srpt) stock options. According to Zacks on Thursday, 19 September, "Currently, Sarepta Therapeutics is a Zacks Rank #3 (Hold) in the Medical- Biomedical and Genetics industry that ranks in the Top 32% of our Zacks Industry Rank. ", "Given the way analysts feel about Sarepta Therapeutics right now, this huge implied volatility could mean there’s a trade developing. "
2. QuickLogic Corporation (QUIK)
34.4% sales growth and 10.55% return on equity
QuickLogic Corporation, a semiconductor company, develops semiconductor platforms and intellectual property solutions for smartphones, wearable, hearable, tablets, and the Internet-of-Things devices. It also provides flexible sensor processing solutions, ultra-low power display bridges, ultra-low power field programmable gate arrays (FPGAs); and analytics toolkit, an end-to-end software suite that offers processes for developing pattern matching sensor algorithms using machine learning technology, as well as programming hardware and design software solutions. The company's products include pASIC 3, QuickRAM, QuickPCI, EOS, QuickAI, SensiML Analytics Studio, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II, as well as silicon platforms, IP cores, software drivers, firmware, and application software. It delivers its solutions through ultra-low power customer programmable System on Chip (SoC) semiconductor solutions, embedded software, and algorithm solutions for always-on voice and sensor processing, and enhanced visual experiences. In addition, the company licenses FPGA technology for use in other semiconductor companies SoCs. It markets and sells its products to original equipment manufacturers and original design manufacturers through a network of sales managers and distributors in North America, Europe, and the Asia Pacific. QuickLogic Corporation was founded in 1988 and is headquartered in San Jose, California.
Earnings Per Share
As for profitability, QuickLogic Corporation has a trailing twelve months EPS of $0.14.
PE Ratio
QuickLogic Corporation has a trailing twelve months price to earnings ratio of 60. Meaning, the purchaser of the share is investing $60 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.55%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 138.5% and positive 55.6% for the next.
Sales Growth
QuickLogic Corporation’s sales growth for the next quarter is 34.4%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 41.3%, now sitting on 24.28M for the twelve trailing months.
Moving Average
QuickLogic Corporation’s worth is way below its 50-day moving average of $10.04 and way below its 200-day moving average of $12.52.
3. Argan (AGX)
28.9% sales growth and 14.69% return on equity
Argan, Inc., through its subsidiaries, provides engineering, procurement, construction, commissioning, operations management, maintenance, project development, technical, and consulting services to the power generation and renewable energy markets. The company operates through Power Industry Services, Industrial Fabrication and Field Services, and Telecommunications Infrastructure Services segments. The Power Industry Services segment offers engineering, procurement, and construction (EPC) contracting services to the owners of alternative energy facilities, such as biomass plants, wind farms, and solar fields; and design, construction, project management, start-up, and operation services for projects with approximately 15 gigawatts of power-generating capacity. This segment serves independent power project owners, public utilities, power plant equipment suppliers, and energy plant construction companies. The Industrial Fabrication and Field Services segment provides industrial field, and steel pipe and vessel fabrication services for forest products, power, energy, large fertilizer, EPC, mining, and petrochemical companies in southeast region of the United States. The Telecommunications Infrastructure Services segment offers trenchless directional boring and excavation for underground communication and power networks, as well as aerial cabling services; and installs buried cable, high and low voltage electric lines, and private area outdoor lighting systems. It also provides structuring, cabling, terminations, and connectivity that offers the physical transport for high speed data, voice, video, and security networks. This segment serves state and local government agencies, regional communications service providers, electric utilities, and other commercial customers, as well as federal government facilities comprising cleared facilities in the mid-Atlantic region of the United States. Argan, Inc. was founded in 1961 and is headquartered in Rockville, Maryland.
Earnings Per Share
As for profitability, Argan has a trailing twelve months EPS of $3.19.
PE Ratio
Argan has a trailing twelve months price to earnings ratio of 28.05. Meaning, the purchaser of the share is investing $28.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.69%.
Sales Growth
Argan’s sales growth for the next quarter is 28.9%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 215% and 24.7%, respectively.
Volume
Today’s last reported volume for Argan is 256157 which is 21.44% above its average volume of 210920.
Yearly Top and Bottom Value
Argan’s stock is valued at $89.48 at 11:22 EST, under its 52-week high of $95.73 and way higher than its 52-week low of $39.74.
4. Chimera Investment Corporation (CIM)
14.6% sales growth and 8.38% return on equity
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency and non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, and other real estate related securities. It has elected to be taxed as a REIT and would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its shareholders. The company was incorporated in 2007 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Chimera Investment Corporation has a trailing twelve months EPS of $1.7.
PE Ratio
Chimera Investment Corporation has a trailing twelve months price to earnings ratio of 9.06. Meaning, the purchaser of the share is investing $9.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.38%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 28, 2024, the estimated forward annual dividend rate is 1.4 and the estimated forward annual dividend yield is 8.95%.
Moving Average
Chimera Investment Corporation’s worth is higher than its 50-day moving average of $14.66 and way above its 200-day moving average of $13.91.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22.9%, now sitting on 306.42M for the twelve trailing months.
5. Myers Industries (MYE)
12.8% sales growth and 13.73% return on equity
Myers Industries, Inc. engages in distribution of tire service supplies in Ohio. It operates through two segments, The Material Handling and Distribution. The Material Handling segment offers pallets, small parts bins, bulk shipping containers, and OEM parts, as well as storage and organization, and custom plastic products; and injection molded, rotationally molded or blow molded products, consumer fuel containers and tanks for water, fuel, and waste handling. It serves industrial manufacturing, food processing, retail/wholesale products distribution, agriculture, automotive, recreational and marine vehicles, healthcare, appliance, bakery, electronics, textiles, consumer markets, and other markets under Akro-Mils, Jamco, Buckhorn, Ameri-Kart, Scepter, Elkhart Plastics, and Trilogy Plastics brands directly to end-users, as well as through distributors. The Distribution segment engages in the distribution of tools, equipment, and supplies for tire, wheel, and under-vehicle service on passenger, heavy truck, and off-road vehicles; and manufacture and sale of tire repair materials and custom rubber products, as well as reflective highway marking tapes under the Myers Tire Supply, Myers Tire Supply International, Tuffy Manufacturing, Mohawk Rubber Sales, Patch Rubber Company, Elrick, Fleetline, MTS, Seymoure, Advance Traffic Markings, and MXP brands. This segment serves retail and truck tire dealers, commercial auto and truck fleets, auto dealers, general service and repair centers, tire re-treaders, truck stop operations, and government agencies. The company was founded in 1933 and is headquartered in Akron, Ohio.
Earnings Per Share
As for profitability, Myers Industries has a trailing twelve months EPS of $1.05.
PE Ratio
Myers Industries has a trailing twelve months price to earnings ratio of 13.1. Meaning, the purchaser of the share is investing $13.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.73%.
Sales Growth
Myers Industries’s sales growth for the next quarter is 12.8%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Sep 13, 2024, the estimated forward annual dividend rate is 0.54 and the estimated forward annual dividend yield is 3.93%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.7%, now sitting on 816.21M for the twelve trailing months.
6. Walker & Dunlop (WD)
11.4% sales growth and 4.7% return on equity
Walker & Dunlop, Inc., through its subsidiaries, originates, sells, and services a range of multifamily and other commercial real estate financing products and services for owners and developers of real estate in the United States. The company offers first mortgage, second trust, supplemental, construction, mezzanine, preferred equity, and small-balance loans. It also provides finance for multifamily, manufactured housing communities, student housing, affordable housing, and senior housing properties under the Fannie Mae's DUS program; and construction and permanent loans to developers and owners of multifamily housing, affordable housing, senior housing, and healthcare facilities. In addition, the company acts as a debt broker to work with life insurance companies, banks, and other institutional lenders to find debt and/or equity solution for the borrowers' needs; and offers property sales brokerage services to owners and developers of multifamily properties, and commercial real estate and multifamily property appraisals for various investors. Further, it provides appraisal and valuation services; and real estate-related investment banking and advisory services, including housing market research. Additionally, the company offers servicing and asset-managing the portfolio of loans; originates loans through its principal lending and investing activities; and manages third-party capital invested in tax credit equity funds focused on the affordable housing and other commercial real estate sectors. Walker & Dunlop, Inc. was founded in 1937 and is headquartered in Bethesda, Maryland.
Earnings Per Share
As for profitability, Walker & Dunlop has a trailing twelve months EPS of $2.59.
PE Ratio
Walker & Dunlop has a trailing twelve months price to earnings ratio of 41.92. Meaning, the purchaser of the share is investing $41.92 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.7%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Aug 22, 2024, the estimated forward annual dividend rate is 2.6 and the estimated forward annual dividend yield is 2.39%.
